Travelgum 20 mg medicated chewing gum

Travelgum is a well-known medicated chewing gum used primarily for the prevention and treatment of motion sickness (kinetosis) symptoms like nausea and vomiting. The active ingredient is dimenhydrinate.

The brand was originally developed and marketed by various pharmaceutical entities over the decades, notably under the Meda brand. However, since the acquisition of Meda by Viatris (formed via the merger of Mylan and Upjohn), the product has become part of a massive global healthcare portfolio. In Italy, where the product in the image is popular, it is distributed and managed by Viatris Inc. through its local subsidiaries. Production is typically focused in European pharmaceutical facilities, particularly in Italy.